Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Jul;6(Suppl 1):S6-8.
doi: 10.4103/0975-7406.137249.

Theranostics: A treasured tailor for tomorrow

Affiliations
Review

Theranostics: A treasured tailor for tomorrow

S Jeelani et al. J Pharm Bioallied Sci. 2014 Jul.

Abstract

Emerging as a targeted, safe, and efficient pharmacotherapy is the approach of theranostics, which focuses on patient-centered care. It is a combination of diagnosis and therapeutics. It provides a transition from conventional medicine to personalized medicine. It deals with the custom made treatment plan based on uniqueness of every individual thus resulting in right drug for the right patient at the right time. Genetics plays a significant role in theranostics. Theranostics provides a cost-effective specific successful treatment protocol. Pharmacogenetics, proteomics and biomarker profiling forms the backbone of theranostics. The role of theranostics is interestingly appreciated at multi levels with special consideration in oncology wherein nano formulations in the form of liposomes, dendrimers, polymeric nanoparticles, metallic nanoparticles, quantum dots and carbon nanotubes play a very important role. Thus, theranostics is a holistic transition from trial and error medicine to predictive, preventive and personalized medicine leading to improved quality care of pharmacotherapy.

Keywords: Diagnosis; personalized medicine; theranostics; therapy.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

References

    1. Mitri Z, Esmerian MO, Simaan JA, Sabra R, Zgheib NK. Pharmacogenetics and personalized medicine: The future for drug prescribing. J Med Liban. 2010;58:101–4. - PubMed
    1. Ruano G. Quo vadis personalized medicine? Pers Med. 2004;1:1–7. - PubMed
    1. Landais P, Méresse V, Ghislain JC. Evaluation and validation of diagnostic tests for guiding therapeutic decisions. Therapie. 2009;64:187–201. - PubMed
    1. Lin W. Molecular diagnostic renovates drug development: overcoming challenges of co-development of theranostics. Trends Bio/Pharm Ind. 2007;4:26–8.
    1. Pene F, Courtine E, Cariou A, Mira JP. Toward theragnostics. Crit Care Med. 2009;37:S50–8. - PubMed